Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

0.679

Today's Change

+0.01 (1.49%)

Day's Change

0.65 - 0.679

Trading Volume

1,262,610

Overview

Market Cap

246 Million

Shares Outstanding

363 Million

Avg Volume

15,476,204

Avg Price (50 Days)

0.50

Avg Price (200 Days)

1.14

PE Ratio

-1.08

EPS

-0.63

Earnings Announcement

30-Apr-2025

Previous Close

0.67

Open

0.67

Day's Range

0.65 - 0.6791

Year Range

0.28 - 2.45

Trading Volume

1,264,533

Price Change Highlight

1 Day Change

1.54%

5 Day Change

-5.68%

1 Month Change

19.04%

3 Month Change

-17.12%

6 Month Change

-65.17%

Ytd Change

-12.61%

1 Year Change

-55.90%

3 Year Change

-64.81%

5 Year Change

-64.07%

10 Year Change

-90.30%

Max Change

-99.48%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment